Successful use of Samarium 153 for emergency treatment of disseminated intravascular coagulation due to metastatic hormone refractory prostate cancer.
Ruffion
A
A
Departments of Urologic Surgery and Nuclear Medicine, Jules Courmont Hospital and Department of Urologic Surgery, Antiquaille Hospital, Lyon, France.
Manel
A
A
Valignat
C
C
Lopez
J G
JG
Perrin-Fayolle
O
O
Perrin
P
P
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary*; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000532:radiotherapy*; D005884:Gingival Hemorrhage / Q000532:radiotherapy; D006406:Hematoma / Q000532:radiotherapy; D006489:Hemostatic Techniques; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy; D011868:Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000627:therapeutic use*; D012493:Samarium / Q000008:administration & dosage / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D011868:Radioisotopes; D019275:Radiopharmaceuticals; D012493:Samarium